When was Nanosphere founded?

Nanosphere was founded in 1999 and raised its 1st funding round 1 year after it was founded.

Where is Nanosphere located?

Nanosphere is headquartered in Northbrook, United States.

How many employees does Nanosphere have?

As of May 31, 2026, the latest employee count at Nanosphere is 40.

Is Nanosphere a funded company?

Nanosphere is a funded company, having raised a total of $97.7M across 11 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 2000.

When was the latest funding round of Nanosphere?

Nanosphere's latest funding was a $***** Post IPO round on Dec 17, 2018, with participation from 0 investor. Its primary sector is Nanotechnology. In United States, the Nanotechnology sector has seen $117M in funding in 2026 to date.

Where does Nanosphere rank among its competitors?

Nanosphere ranks 48th amongst 399 active competitors, of which 133 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Adela, which secured $5M in Apr, 2026.

Who are the top competitors of Nanosphere?

Nanosphere's top competitors include MedGenome, Caris Life Sciences and Geneoscopy. Among them, Adela secured the most recent funding round in April, 2026.

Nanosphere - 2026 Company Profile, Funding & Competitors

Nanosphere is an acquired company based in Northbrook (United States), founded in 1999. It operates as a Provider of diagnostic tests for personalized medicine. Nanosphere has raised $97.7M in funding from Bain Capital Ventures and Ann Lurie. The company has 399 active competitors, including 133 funded and 85 that have exited. Its top competitors include companies like MedGenome, Caris Life Sciences and Geneoscopy.

Company Details

Provider of diagnostic tests for personalized medicine. It targets infections of the bloodstream, respiratory tract and gastrointestinal tract. Their Verigene System utilizes automation and proprietary chemistry to enable direct detection of nucleic acids and protein detection on the same platform. All tests offered by the company are built around Nanosphere's gold nanoparticle probe technology

Website: www.nanosphere.us/support/flex-usage-support
Social

Key Metrics

Founded Year

1999

Location

Northbrook, United States

Stage

Acquired

Total Funding

$97.7M in 11 rounds

Latest Funding Round

Post IPO, Dec 17, 2018, $*****

Investors

Bain Capital Ventures & 9 more

Ranked

48^th among 399 active competitors

Employee Count

40 as on May 31, 2026

Similar Companies

MedGenome & 567 more

Exit Details

Acquired by Luminex (May 16, 2016)

View Nanosphere's full profile

Nanosphere is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Nanosphere, Inc. CIN: 364339870 , United States, Active	Dec 31, 1999	-	146 (As on Dec 31, 2016)	-

Nanosphere got acquired by Luminex on May 16, 2016.

Click here to take a look at Nanosphere's acquisition in detail

Nanosphere has raised a total funding of $97.7M over 11 rounds. Its first funding round was on Mar 2000. Nanosphere has 10 institutional investors.

Here is the list of recent funding rounds of Nanosphere:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 17, 2018	7022340	Post IPO	9372498	4269195	9173687	1545483
May 15, 2015	4232508	Conventional Debt	8180233	2100622	9118779	Life Sciences Alternative Funding & 1 more
Mar 23, 2010	4685643	Grant (prize money)	3919543	1435079	1111025	Military Health

Access funding benchmarks and valuations. Sign up today!

View details of Nanosphere's funding rounds and investors

Nanosphere's employee count trend

Nanosphere has 40 employees as of May 26. Here is Nanosphere's employee count trend over the years:

Uncover Nanosphere's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nanosphere include MedGenome, Caris Life Sciences and Geneoscopy. Here is the list of Top 10 competitors of Nanosphere, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	71/100
2nd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Braidwell & 19 others	70/100
3rd	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
4th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Orbimed & 10 others	66/100
5th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	Khosla Ventures, SoftBank Vision Fund & 16 others	63/100
6th	Precipio Diagnostics 1997, New Haven (United States), Public	Provider of cancer diagnostics and second opinion tools	$800K	Enhanced Capital, Connecticut Innovations ... & 3 others	63/100
7th	Adela 2021, San Francisco (United States), Series A	Developer of a platform for detection of cancer	$139M	LabCorp, Deerfield Mg & 5 others	62/100
8th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Foresite Capital & 11 others	62/100
9th	Ambrx 2003, San Diego (United States), Acquired	Developer of Antibody drug conjugates to treat cancers, metabolic disorders and cardiovascular disorders	$346M	Glynn Capital, Fidelity Investments & 24 others	61/100
10th	Exicure 2009, Skokie (United States), Public	developer of gene silencing & immunomodulatory drugs using spherical nucleic acid (SNA) technology	$72.3M	Abbott Biotech Ventures, Luye Pharma & 18 others	61/100
48th	Nanosphere 1999, Northbrook (United States), Acquired	Provider of diagnostic tests for personalized medicine	$97.7M	Western Technology Investment, Allen & Company ... & 8 others	52/100